Article
JAMA reports a safety survey of hospital employees showing that the risk of anaphylaxis from mRNA vaccines is 2.47 per 10,000 individuals.
All News
Article
There is a growing body of evidence regarding COVID-19 outcomes (including death) in rheumatic disease patients; analysis of a German registry shows that poor control, rituximab, sulfasalazine and other immunosuppressives could be risk factors for COVID-related death.
Article
On Feb. 27, the Food and Drug Administration announced it has issued an emergency use authorization for Johnson & Johnson’s one-dose Covid vaccine, making it the third COVID-19 vaccine to be commercially available. We've compiled a comparison table and some key information relevant to your delivering patient guidance henceforth.
Article
Among 330 million Americans, roughly 32.1 million have been fully vaccinated and 61.1 million have received at least one dose of a COVID-19 vaccine (as of March 8th).
Dr. John Cush
Tweet
Metanalysis of 45 studies, ∼175 000 individuals shows a significant association between pain and socioeconomic status (SES).Chronic pain was higher with low SES (OR 1.32) and medium SES level (OR 1.16) https://t.co/0MM0V1WUhi
Dr. John Cush
Tweet
Population claims based study of RA patients shows improvement in the 10-year risk of acute myocardial infarction over time (same as the general population). Nevertheless, RA pts have a 21 % higher risk of AMI than the matched general population https://t.co/zfsJftR9ZA
Dr. John Cush
Tweet
Free read on the 20 year history, immunology and targeting of interleukin-17 (IL-17) Great article by Professor Pierre Miossec https://t.co/69acTuPWZZ
Dr. John Cush
Tweet
We are just about one week out. Have you registered to attend? We have a robust schedule planned with digital access to all content and downloads.
https://t.co/Woxi4Ri0O5 https://t.co/ADll6r8dFu
Dr. John Cush
Tweet
QD Clinic - Notalgia?
Get a Clue - to the Dx of FM
https://t.co/LRC7e8PPla https://t.co/K4pkWq39OC
Dr. John Cush
Tweet
RheumNow Live is a powerful, interactive meeting delivered by researchers, educators, & clinicians.
Sign up to attend virtually or in-person today.
https://t.co/LJ3qClHTKh https://t.co/K3YgfFZhpa
Dr. John Cush
Tweet
QD Clinic - Ms. RA
Can Multiple Sclerosis and RA Coexist? What Drugs can be used?
https://t.co/PYFQI7vn3M
Dr. John Cush
Tweet
Analysis of US National Inpatient Sample (2000‐2014). In #RA pts, there was a signif decline in annual rate of hospitalizations (76per million in 2000 to 30 per million 2014) & Hosp mortality (0.70% to 0.41%); but a signif incr in hosp for arthroplasty https://t.co/kkpmdKzEhQ
Dr. John Cush
Tweet
75 RA pts on MTX >3 yrs had FIBROSCANS done to assess their value. 12 pts (16%) had Fibroscan ≥ 7.1 kPa, 3 patients w/ severe liver stiffness (9.5 to 12.5 kPa) & 1 w/ cirrhosis range scores (> 12.5 kPa). No Bx were done; LFTs were not predictive https://t.co/Pi1h1nF0Uq
Dr. John Cush
Tweet
News Feature: CDC: Interim Guidance for COVID Vaccinated People
https://t.co/3GZDCVF0hv https://t.co/qyQyajjqM8
Dr. John Cush
Tweet
2020 Year in Review - Top Publications in SpA and Still’s Disease
Sponsored by Novartis Medical Affairs
Listen to medical experts discuss their latest insights in spondyloarthritis and Still’s disease.
View Now: https://t.co/rxTAwQNalx https://t.co/bmjrEdkf89
Dr. John Cush
Tweet
Matched cohort study f142 Takayasu arteritis pts - incidence 0.8 per million/Yr. TAK had increased in All‐cause mortality (adj HR 1.88 ;1.29–2.76), ischemic heart dz, CVA, TIA, CVD, PVD - but not HTN, CHF or DM. Only ~50% were on statins or anti-Plt Rx https://t.co/rgNqkha6sq
Dr. John Cush
Tweet
Swedish registry looked at odds of achieving remission with either Triple DMARD (347 MSH) or biologic Rx (1155) - more pts on biologics achieved remission at 1 yr (OR 1.79;1.18‐2.72) and 2 yrs (OR 1.92;1.21‐3.06). https://t.co/1MwhDbNxbf
Dr. John Cush
Tweet
Analysis of 8416 pts w/ Kawasaki disease (KD) shows older and younger children differ. <10% were under 6 mos, 78%) were 6 mos-4yrs; 11% 5 to 9 yrs. Younger KD had more incomplete KD, coronary aneurysms, while older had more delayed diagnoses, more fever https://t.co/NkSmfg38ru
Dr. John Cush
Tweet
The Reflecting Rheum: 2020 SpA and Still’s Disease Highlights
Sponsored by Novartis Medical Affairs
Listen to a discussion of medical experts share their views on the most impactful work done in spondyloarthritis and Still’s disease in 2020.
https://t.co/rxTAwQNalx https://t.co/OEbHRn3gKP
Dr. John Cush
Tweet
Blinded by Noncompliance--New QD Clinic
Suggestions on Optimizing Compliance in the Clinic
https://t.co/tBnjBX68O8 https://t.co/uZ3aA7bnTJ
